Whistleblower complaint from doctor formerly leading U.S. coronavirus vaccine effort alleges HHS operated on 'cronyism'

Dr Rick Bright, who was formerly leading the federal government's coronavirus vaccine development, officially filed his whistleblower complaint on Tuesday. Bright reiterated that he believes he was removed from his post as the director of the Department of Health and Human Services' Biomedical Advanced Research and Development Authority (and transferred to a "less impactful" position) because he refused to back President Trump's preferred, but unproven coronavirus treatment, hydroxychloroquine.
Additionally, Bright's complaint echoes other reports that members of the Trump administration received early warnings about the possibility that China's coronavirus outbreak could result in a pandemic. He singled out HHS Secretary Alex Azar as someone who resisted Bright's quest for resources to combat the virus' spread. But his allegations don't just revolve around COVID-19.
The complaint also describes a culture of "cronyism" within the HHS since the nascent days of the Trump administration in 2017. While Bright was running BARDA, the complaint said, he was determined to award contracts to companies looking to develop essential drugs, vaccines, and diagnostics based solely on scientific merit. But he allegedly clashed with top HHS officials, including HHS Assistant Secretary Dr. Robert Kadlec, who "pressured" Bright to "ignore expert recommendations" and "award lucrative contracts based on political connections." A lot of the tension reportedly stemmed from what Bright described as the "outsized" influence of John Clerici, a pharmaceutical industry consultant with longstanding ties to Kadlec.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Eventually, the complaint alleges, that led to "some discord" between Bright and HHS leadership that lasted until his recent removal. Read the full complaint here.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
US foodies brace for tariff war
Under The Radar Shoppers stocking up on imported olive oil, maple syrup and European wine as price hikes loom
By Chas Newkey-Burden, The Week UK Published
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published